Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP science news

Show

From To
“Intensive Combination Prevention” proposal for gay men in England would include PrEP

A pilot rollout in England of a new, standardised intensive HIV prevention package for gay men at high risk of HIV infection would include a substudy in

Published
15 April 2011
By
Gus Cairns
‘Near perfect’ adherence in early stages of Partners PrEP study

Very high levels of adherence have been achieved in one of the ongoing randomised controlled trials of oral pre-exposure prophylaxis (PrEP), according to a poster presentation at

Published
29 March 2011
By
Gus Cairns
First pills-versus-gel trial finds US women prefer oral PrEP

The first head-to-head trial directly comparing the acceptability of tenofovir pills and tenofovir microbicide gel amongst HIV-negative women has found that, while African women liked both products

Published
02 March 2011
By
Gus Cairns
New data from PrEP study shed light on adherence, bone mineral loss and resistance

Near-perfect adherence to oral pre-exposure prophylaxis – taking HIV drugs to prevent HIV – may be achievable in the right settings, the Eighteenth Conference on Retroviruses and

Published
02 March 2011
By
Gus Cairns
Truvada PrEP remains effective against HIV with 3TC/FTC resistance in animal study

The US Centers for Disease Control (CDC) has found that oral pre-exposure prophylaxis (PrEP) using a combined tenofovir/FTC (Truvada) pill is still effective against HIV with the

Published
28 February 2011
By
Gus Cairns
PrEP, the big issues: iPrEx study directors discuss unanswered questions

The success of the iPrEx study of pre-exposure prophylaxis (PrEP) in gay men opens up as many urgent questions as it has answered. This became clear as

Published
23 November 2010
By
Gus Cairns
Anti-HIV drugs prevent HIV infection, trial shows – if you take them

A randomised controlled trial has found that the HIV infection rate in HIV-negative gay men who were given a daily preventative pill containing two HIV drugs was reduced

Published
23 November 2010
By
Gus Cairns
Second-ever pre-exposure prophylaxis study reports no safety concerns and promising result

The last day of the Vienna International AIDS Conference featured the results of the second-ever completed randomised controlled trial of pre-exposure prophylaxis (PrEP) – giving antiretrovirals to

Published
23 July 2010
By
Gus Cairns
Microbicides and circumcision could achieve modest cuts in HIV infections in Africa

Three mathematical models presented at the Eighteenth International AIDS Conference in Vienna have found that circumcision and a microbicide, used separately or together, could produce modest reductions

Published
22 July 2010
By
Gus Cairns
PrEP could reduce condom use by some gay men

A substantial proportion of gay men say they would reduce their condom use if pre-exposure prophylaxis (PrEP) proves to be effective, US investigators report in

Published
14 June 2010
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.